Dear Sir/Madam, Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on Monday, May 29, 2023 has considered and approved the appointment of Mr. Anand Menon, as a whole-time Chief Executive Officer and Key Managerial Personnel of the Company with effect from May 29, 2023. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015, dated September 09, 2015 are enclosed as Annexure I. We request you to take the same on record. Thanking you, Yours faithfully, For EP Biocomposites Limited Akshada Neugui Company Secretary and Compliance Officer